Syndax Pharmaceuticals SG&A Expense (TTM) Trends

Syndax Pharmaceuticals Inc (SNDX)

20.55 +0.23 (+1.13%) USD | NASDAQ | Jun 28, 16:00

20.54 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	77.98M
December 31, 2023	66.92M
September 30, 2023	54.34M
June 30, 2023	45.31M
March 31, 2023	38.38M
December 31, 2022	33.26M
September 30, 2022	29.99M
June 30, 2022	28.55M
March 31, 2022	26.41M
December 31, 2021	25.24M
September 30, 2021	23.03M
June 30, 2021	22.06M
March 31, 2021	22.26M
December 31, 2020	22.50M
September 30, 2020	22.87M
June 30, 2020	20.65M
March 31, 2020	18.07M
December 31, 2019	16.06M
September 30, 2019	14.87M
June 30, 2019	15.39M
March 31, 2019	16.41M

Date	Value
December 31, 2018	17.29M
September 30, 2018	17.48M
June 30, 2018	16.92M
March 31, 2018	16.72M
December 31, 2017	15.86M
September 30, 2017	14.75M
June 30, 2017	14.46M
March 31, 2017	12.98M
December 31, 2016	13.32M
September 30, 2016	12.75M
June 30, 2016	12.67M
March 31, 2016	13.15M
December 31, 2015	11.59M
September 30, 2015	11.03M
June 30, 2015	13.86M
March 31, 2015	12.02M
December 31, 2014	11.16M
September 30, 2014	11.14M
June 30, 2014	6.555M
March 31, 2014	6.471M
December 31, 2013	5.363M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

14.87M

Minimum

Sep 2019

77.98M

Maximum

Mar 2024

32.04M

Average

25.24M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks